Antimicrobial potential of stingless bee honey in infections caused by Escherichia coli
Keywords:
bees; Escherichia coli; honey; infectionsAbstract
Introduction: The growing resistance of Escherichia coli to antimicrobials drives the search for natural alternatives with therapeutic potential. Stingless bee honey, recognized for its antimicrobial properties, has demonstrated efficacy against pathogenic bacteria in various studies.
Objective: To describe the antimicrobial potential of stingless bee honey against E. coli infections.
Methods: A narrative review was conducted of articles published between January 2020 and June 2026 using databases PubMed, SciELO, and Scopus; 29 relevant studies were selected.
Development: Scientific evidence indicates that stingless bee honey exerts antimicrobial activity against E. coli infections through multiple factors acting synergistically: the presence of hydrogen peroxide, low pH, high sugar-induced osmolarity, phenolic compounds, and antimicrobial peptides. The combination of these factors hinders the development of bacterial resistance compared to conventional antibiotics. In vitro studies show that this honey can inhibit the growth of E. coli including resistant strains with inhibition zones averaging 9.09 mm and minimum inhibitory concentrations close to 16.17 g/100 mL. Efficacy varied according to factors such as botanical and geographic origin and the bee species. The potential of the honey as an antibiotic adjuvant and in formulations such as hydrogels and nanoparticles was highlighted.
Conclusions: Stingless bee honey represents a promising natural alternative for E. coli infections. Its synergistic action reduces the likelihood of bacterial resistance and opens up sustainable therapeutic possibilities.
Downloads
References
1. Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, et al. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis. 2025; 25(9):1033-43. DOI: https://doi.org/10.1016/S1473-3099(25)00118-5
2. Ng RWY, Yang L, Lau SH, Hawkey P, Ip M. Global prevalence of human intestinal carriage of ESBL-producing E. coli during and after the COVID-19 pandemic. J Antimicrob Resist. 2025; 7(1): dlaf001. DOI: https://doi.org/10.1093/jacamr/dlaf001
3. Peñaloza Piña LM, Aspiazu Hinostroza KA. Mecanismos de resistencia de Escherichia coli en América Latina. Vive Rev Salud. 2021; 4(11): 90-103. DOI: https://doi.org/10.33996/revistavive.v4i11.88
4. Belmont Monroy L, Merida Vieyra J, Bautista Hernández R, Mateo Arreola JA, de Colsa Ranero A, Medina Vera I, et al. Escherichia coli causing bloodstream infections in Mexican paediatric patients: molecular typing, antimicrobial resistance, virulence factors, and clinical features. BMC Infect Dis. 2025; 25(1): 764. DOI: https://doi.org/10.1186/s12879-025-11163-3
5. Quiñones Pérez D, Betancourt González Y, Carmona Cartaya Y, Pereda Novales N, Álvarez Valdivia S, Soe aung M, et al. Escherichia coli extraintestinal, resistencia antimicrobiana y producción de betalactamasas en aislados cubanos [Internet]. Rev Cubana Med Trop. 2020 [acceso: 29/09/2025]; 72(3): e605. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602020000300006
6. Jaime Castillo M, Morell León LR, Díaz Rodríguez NE, González Méndez A. Escherichia infections coli associated with healthcare at Camilo Cienfuegos General Hospital. J. General Medicine and Clinical Practice. 2025; 8(8): 1-5. DOI: https://doi.org/10.31579/2639-4162/278
7. Martínez Castro A, Pupo Y, González M, Ramírez F. Productos apícolas como alternativa terapéutica en el enfoque Una Salud: revisión integradora. Rev Cubana Salud Pública. 2025; 51(1): e1234. DOI: https://doi.org/10.52379/rcsp.2025.1234
8. Rosli FN, Hazemi MHF, Akbar MA, Basir S, Kassim H, Bunawan H. Stingless bee honey: evaluating its antibacterial activity and bacterial diversity. Insects. 2020; 11(8): 500. DOI: https://doi.org/10.3390/insects11080500
9. Gadge AS, Dhembare AJ. Physiochemical, biological, and therapeutic uses of stingless bee honey: a review. Front Sustain Food Syst. 2024; 7: 1324385. DOI: https://doi.org/10.3389/fsufs.2023.1324385
10. Cabezas Mera F, Cedeño Pinargote AC, Tejera E, Álvarez Suarez JM, Machado A. Antimicrobial activity of stingless bee honey (Tribe: Meliponini) on clinical and foodborne pathogens: a systematic review and meta-analysis. Food Front. 2024; 5(3): 964-93. DOI: https://doi.org/10.1002/fft2.386
11. Fernandes KE, Levina A, Cokcetin NN, Haley D, Li J, Brooks P, et al . Strong antimicrobial activity and unique physicochemical characteristics in honey from Australian stingless bees Tetragonula carbonaria, Tetragonula hockingsi and Austroplebeia australis. Appl Environ Microbiol. 2025; 91(6): e02523-24. DOI: https://doi.org/10.1128/aem.02523-24
12. Grinn Gofroń A, Kołodziejczak M, Hrynkiewicz R, Lewandowski F, Bębnowska D, Adamski C, et al. Antimicrobial potential of bee-derived products: insights into honey, propolis and bee venom. Pathogens. 2025; 14(8): 780. DOI: https://doi.org/10.3390/pathogens14080780
13. Ja’afar NL, Ab Aziz NA, Zakaria Z, Mustapha M, Mohamed M, Mustafa MZ, et al. A narrative review on the physicochemical profiles, bioactive compounds, and therapeutic potentials of stingless bee honey. Discov Food. 2025; 5: 150. DOI: https://doi.org/10.1007/s44187-025-00429-z
14. Zulkifli NA, Mohd Faudzi SM, Md Saad N, Mohd Kamal K. The potential neuroprotective effects of stingless bee honey. Saudi J Biol Sci. 2023; 30(2):103522. DOI: https://doi.org/10.1016/j.sjbs.2023.103522
15. Tlak Gajger I, Dar SA, Ahmed MMM, Aly MM, Vlainić J. Antioxidant Capacity and Therapeutic Applications of Honey: Health Benefits, Antimicrobial Activity and Food Processing Roles. Antioxidants. 2025; 14(8): 959. DOI: https://doi.org/10.3390/antiox14080959
16. Tiang ER, Han L, Hu F. Physicochemical Characteristics, Antioxidant Capacity, and Antimicrobial Activity of Stingless Bee Honey from Malaysia: Heterotrigona itama, Lophotrigona canifrons, and Tetrigona binghami. Foods. 2025; 14(6): 995. DOI: https://doi.org/10.3390/foods14060995
17. Faleiros Quevedo M, Silva GR, Dos Santos AN, Francoy TM. Honey from different species of stingless bees (Apidae: Meliponini) is effective against Gram-positive and Gram-negative bacteria. J Med Food. 2025; 28(2): 198-204. DOI: https://doi.org/10.1089/jmf.2023.0107
18. Ramón Sierra JM, Villanueva MA, Yam Puc A, Rodríguez Mendiola M, Arias Castro C, Ortiz Vázquez E. Antimicrobial and antioxidant activity of proteins isolated from Melipona beecheii honey . Food Chem X. 2021; 13: 100177. DOI: https://doi.org/10.1016/j.fochx.2021.100177
19. Jilo KR. Stingless Bee (Meliponulla baccaerii) honey antibacterial activities against Salmonella typhi, Escherichia coli, Staphylococcus aureus and Enterococcus faecalis . J Bacteriol Parasitol. 2024; 15(2): 50. DOI: https://doi.org/10.35248/2155-9597.24.15.506
20. Bahari N, Hashim N, Abdan K, Mohd Akim A, Maringgal B, Al-Shdifat L. Green-synthesised silver and zinc oxide nanoparticles from stingless bee honey: Morphological characterisation, antimicrobial action, and cytotoxic assessment. Chemosphere. 2025; 370: 143961. DOI: https://doi.org/10.1016/j.chemosphere.2024.143961
21. Wavinya F, Omolo M, Malebo H, Sifuna A, Nyongesa P, Nonoh J. Antibacterial activity of honey from wild species of stingless bees; Plebeia hylderbrandii and Meliponula bocandei . J Biosci Med. 2021; 9(7): 1-12. DOI: https://doi.org/10.4236/jbm.2021.97009
22. Razali MF, Aripin J, Iderus NN, Mohd Adnan NS, Mohd Fauzi NA. Combination of Thermal-Treated Kelulut (Stingless Bee) Honey and Phyllanthus niruri Extract: Evaluation on Antibacterial Activity Against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Staphylococcus epidermidis. Trends Sci 2023; 20(10): 5942. DOI: https://doi.org/10.48048/tis.2023.5942
23. Aburayyan WS, Seder N, Al-Fawares O, Fararjeh A, Majali IS, Al-Hajaya Y. Characterization of Antibiofilm and Antimicrobial Effects of Trigona Stingless Bee Honey Compared to Stinging Bee Centaurea hyalolepis and Citrus Honeys. J Evid Based Integr Med. 2024; 29: 2515690X241271978. DOI: https://doi.org/10.1177/2515690X241271978
24. Damayanti E, Nabila TT, Fitrianto N, Wanita YP, Mahara FA, Herlina VT, et al. Genomic, metabolomic, and functional properties of probiotic lactic acid bacteria isolated from Indonesian stingless bee honey. Int Microbiol. 2026; 29: 509‑31. DOI: https://doi.org/10.1007/s10123-026-00794-4
25. Fajari NM, Pranoto A, Perdanakusuma DS, Salsabila NN, Azzahra AF, Agustin DP, et al. Activity of stingless bee honey (Heterotrigona itama) hydrogel against Escherichia coli, Staphylococcus aureus, and Pseudomona aeruginosa. Trop J Nat Prod Res. 2026; 10(4): 8907-10. DOI: https://doi.org/10.26538/tjnpr/v10i4.76
26. Klaithin K, Chuttong B, Hung YT, Peng CC, Lin JA, Lin CF, et al. Effect of bee species on the physicochemical, bioactive, and microbiological properties of longan honey in Thailand . J Food Compos Anal. 2026; 151: 108998. DOI: https://doi.org/10.1016/j.jfca.2026.108998
27. Adalina Y, Gholam GM, Pratama BP, Andrianto D, Rizqiani KD, Sawitri R, et al. Comparative study of Apis mellifera and Heterotrigona itama honeys from different Indonesian regions on bioactivities, quantitative phenolic profiles, and in silico target engagement. Eur Food Res Technol. 2026; 252(4): 160. DOI: https://doi.org/10.1007/s00217-026-05091-y
28. Mwangi MW, Wanjau TW, Omwenga EO. Stingless bee honey: Nutritional, physicochemical, phytochemical and antibacterial validation properties against wound bacterial isolates. PLoS One. 2024; 19(5): e0301201. DOI: https://doi.org/10.1371/journal.pone.0301201
29. Ng WJ, Sit NW, Ooi PA, Ee KY, Lim TM. The Antibacterial Potential of Honeydew Honey Produced by Stingless Bee (Heterotrigona itama) against Antibiotic Resistant Bacteria. Antibiotics (Basel). 2020; 9(12): 871. DOI: https://doi.org/10.3390/antibiotics9120871.29
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Yazmín Elena Hernández Díaz, Nidia Elena Díaz Rodríguez, Lidia Rosa Guerra Pérez, Miladys Ramos Lage

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.

